Accordingly, we are tempted to speculate whether epigenetic drugs (HDAC and DNMT inhibitors) already in use for some haematologic malignancies [155,156] might be as effective in oesophageal cancer. The gene discussed is DNMT1; the disease is carcinoma of esophagus.